株式会社カワニシホールディングス 2018年6月期第2四半期報告書

This document summarizes the Q2 financial report for the fiscal year ending June 2018 of Kawanishi Holdings Co., Ltd. The company has established a diverse business portfolio ranging from orthopedic, cardiovascular, surgical, ophthalmology to nursing care. The consolidated sales reached 54.563 billion yen, with an operating profit of 740 million yen. Regionally, sales in China increased by 101% year-on-year to 22 billion yen, while Shikoku grew by 107% to 12.3 billion yen. The company is advancing its mid-term management plan focusing on acquiring new revenue sources and improving efficiency, while also engaging in medical device import sales and developing a collaborative model with the medical engineering sector.